Search - tctmd.com

Presenter: Emmanouil S. Brilakis, Aristotelis C. Papayannis, Abdul-rahman R. Abdel-karim, Tesfaldet T. Michael, Arif Mahmood, Lorenza B. Makke, Michele Roesle, Donald Haagen, Bavana V. Rangan, Subhash Banerjee

January 03, 2012

News Daily News

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Jason Kahn

September 12, 2011

News Daily News

Bleeding Increases Mortality as Late as 3 Years After DES

Leah Lawrence

April 18, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

Advertisement

BASKET-SAVAGE: DES Reign for Saphenous Vein Graft PCI Amid Declining Use

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Los SLF y SMD son Ambos Aptos para el Tratamiento de Pacientes con Lesiones IVS

DES、BMS 均适合治疗患隐静脉桥血管病变的患者

DES, BMS Both Suitable for Treating Patients With SVG Lesions

Safety and Clinical Effectiveness of DES for SVG Intervention in Older Individuals

Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study.

ISAR-CABG Published: DES Preferred for Saphenous Vein Graft Lesions

Bleeding Increases Mortality as Late as 3 Years After DES

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content